{"disease":{"id":"triple-negative-breast-cancer-with-disease-progression-on-or-after-chemotherapy-in-the-neoadjuvant-or-adjuvant-setting-and-or-in-patients-with-measurable-disease-by-recist-v1-1.md","name":"triple negative breast cancer with disease progression on or after chemotherapy in the neoadjuvant or adjuvant setting and or in patients with measurable disease by recist v1 1.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}